Antimuscarinics and bladder outlet obstruction: From a contraindication to an indication?
- PMID: 20127792
- DOI: 10.1002/nau.20807
Antimuscarinics and bladder outlet obstruction: From a contraindication to an indication?
Abstract
Aim: To review if the existing data support the new concept that antimuscarinic agents can be used for the treatment of bladder outlet obstruction (BOO) with coexisting overactive bladder (OAB).
Method: A literature search of Medline publications (up to 2008) on use of antimuscarinic agents for treatment BOO was performed and all data were presented. All relevant data from published studies in congress abstracts were as well included.
Results: The existing data show that this treatment effectively improves patient quality of life. Concerns about the possibility of urinary retention were shown to be unfounded. It seems that antimuscarinic agents do not affect voiding pressures and the use of antimuscarinic agents for BOO seems safe.
Conclusions: The combination of an alpha-blocker and antimuscarinic agent for the treatment of BOO with concomitant OAB seems promising.
(c) 2010 Wiley-Liss, Inc.
Comment in
-
Re: Antimuscarinics and bladder outlet obstruction: from a contraindication to an indication?J Urol. 2011 Apr;185(4):1380-1. doi: 10.1016/S0022-5347(11)60312-1. J Urol. 2011. PMID: 22098973 No abstract available.
Similar articles
-
The role of antimuscarinics in the management of men with symptoms of overactive bladder associated with concomitant bladder outlet obstruction: an update.Eur Urol. 2011 Jul;60(1):94-105. doi: 10.1016/j.eururo.2011.03.054. Epub 2011 Apr 9. Eur Urol. 2011. PMID: 21497434 Review.
-
A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladder.Eur Urol. 2006 Apr;49(4):651-8. doi: 10.1016/j.eururo.2006.02.018. Epub 2006 Feb 17. Eur Urol. 2006. PMID: 16530611 Review.
-
Effects of vibegron, a novel β3-adrenoceptor agonist, and its combination with imidafenacin or silodosin in a rat with partial bladder outlet obstruction.Eur J Pharmacol. 2020 Jul 5;878:173096. doi: 10.1016/j.ejphar.2020.173096. Epub 2020 Apr 4. Eur J Pharmacol. 2020. PMID: 32259514
-
Solifenacin plus tamsulosin combination treatment in men with lower urinary tract symptoms and bladder outlet obstruction: a randomized controlled trial.Eur Urol. 2013 Jan;63(1):158-65. doi: 10.1016/j.eururo.2012.07.003. Epub 2012 Jul 17. Eur Urol. 2013. PMID: 22831853 Clinical Trial.
-
[Differences of urodynamic tests between patients of detrusor hyperactivity with impaired contractility with and without bladder outlet obstruction and effect of anticholinergic medications in these patients].Zhonghua Yi Xue Za Zhi. 2012 Jul 10;92(26):1824-7. Zhonghua Yi Xue Za Zhi. 2012. PMID: 22944232 Chinese.
Cited by
-
The Association Between Urinary Tract Infection and Overactive Bladder Treatment.Front Pharmacol. 2022 Jan 25;12:803970. doi: 10.3389/fphar.2021.803970. eCollection 2021. Front Pharmacol. 2022. PMID: 35145406 Free PMC article.
-
An overview of the clinical use of antimuscarinics in the treatment of overactive bladder.Adv Urol. 2011;2011:820816. doi: 10.1155/2011/820816. Epub 2011 Jun 7. Adv Urol. 2011. PMID: 21687579 Free PMC article.
-
Novel drug targets for the pharmacotherapy of benign prostatic hyperplasia (BPH).Br J Pharmacol. 2011 Jul;163(5):891-907. doi: 10.1111/j.1476-5381.2011.01332.x. Br J Pharmacol. 2011. PMID: 21410684 Free PMC article. Review.
-
Adreno-Muscarinic Synergy of Contractile Responses From Human Hyperplastic Prostate.Int Neurourol J. 2024 Feb;28(Suppl 1):46-54. doi: 10.5213/inj.2346144.122. Epub 2024 Feb 29. Int Neurourol J. 2024. PMID: 38461856 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
